Search
for
Sort by
Research 271–300 of 1000+
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Bone vs. fat: Embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts
- Smart DNA biosensor for in vitro detection of androgen receptor mRNA
- 1343 Efficacy of asymmetric siRNA targeting androgen receptor for the treatment of androgenetic alopecia
- Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia
- Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
- Androgens and the hair follicle. Cultured human dermal papilla cells as a model system.
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Managing polycystic ovary syndrome in primary care
- Efficacy of metformin therapy in adolescent girls with androgen excess: relation to sex hormone–binding globulin and androgen receptor polymorphisms
- Alopecia: managing the basics
- Androgens and Hirsutism in a Large Cohort of Portuguese Women
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
- Diagnosis of hyperandrogenism: clinical criteria
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Specific morphogenetic events in mouse external genitalia sex differentiation are responsive/dependent upon androgens and/or estrogens
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Alopecia and Hirsuties
- Hirsutism and virilization
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Androgens and women's health.
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- The Value of Androgen Measures for Diagnosing Polycystic Ovary Syndrome (PCOS) in an Unselected Population